Souhaitez-vous accéder aux communiqués récents ?

Phase III VISION study with 177Lu-PSMA-617 met both primary endpoints, significantly improving overall survival (OS) and radiographic progression-free survival (rPFS) in patients with PSMA-positive...

With eight new configurations, cobas pro® integrated solutions offers labs greater flexibility to ramp up their testing capacity to adapt to evolving testing needsThis will allow a greater number of...

Investigational antibody cocktail of casirivimab and imdevimab also significantly shortened the duration of symptoms by four days The 2,400 mg and 1,200 mg doses tested in the phase III study had...

Dosing to stop in Phase III clinical study of tominersen following recommendation from an Independent Data Monitoring Committee (iDMC)No new safety signals were identified for tominersen in the iDMC’s...

WISeKey $WKEY Selected by Billon Group to Provide MPKI Services Allowing Trusted Remote Document Signing with Blockchain Technologies Geneva – March 22, 2021 – WISeKey International Holding...

Basel, March 22, 2021 — Novartis announced today the appointment of Karen L. Hale as Chief Legal Officer. She will report to Vas Narasimhan, M.D., CEO of Novartis and become a member of the Executive...

First Phase III study to show that a cancer immunotherapy improves disease-free survival in people with resectable early stage lung cancer compared to best supportive care Treating lung cancer early,...

Allschwil, Switzerland – March 19, 2021 Idorsia Ltd (SIX: IDIA) was informed by the Janssen Pharmaceutical Companies of Johnson & Johnson that the US Food and Drug Administration (FDA) has...

Allschwil, Switzerland – March 19, 2021 Idorsia Ltd (SIX: IDIA) was informed by the Janssen Pharmaceutical Companies of Johnson & Johnson that the US Food and Drug Administration (FDA) has...

2021 ANNUAL GENERAL MEETING OF SIKA AG The Board of Directors confirms April 20, 2021 as date for the Annual General MeetingBased on the Ordinance of the Federal Council on measures to prevent...